IL-2 delivery by engineered mesenchymal stem cells re-invigorates CD8+ T cells to overcome immunotherapy resistance in cancer
| Title: | IL-2 delivery by engineered mesenchymal stem cells re-invigorates CD8+ T cells to overcome immunotherapy resistance in cancer |
|---|---|
| Authors: | Bae, JoonbeomAff1; Liu, LongchaoAff1; Moore, CaseyAff1, Aff2; Hsu, EricAff1, Aff2; Zhang, AnliAff1; Ren, ZhenhuaAff1; Sun, ZhichenAff1, Aff3; Wang, XueAff1; Zhu, JiankunAff1; Shen, JiaoAff4, Aff5; Qiao, JianAff1, IDs41556022010245_cor11; Fu, Yang-XinAff1, Aff6, IDs41556022010245_cor12 |
| Source: | Nature Cell Biology. 24(12):1754-1765 |
| Database: | Springer Nature Journals |